Athenex

-$0.11 (-4.18%) Today
+$0.02 (+0.79%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Athenex and other ETFs, options, and stocks.

About ATNX

Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel therapies for the treatment of cancer. It operates through the following segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform.

CEO
Yiu Nam Lau
Employees
605
Headquarters
Buffalo, New York
Founded
2003

ATNX Key Statistics

Market Cap
275.46M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
929.72K
High Today
$2.62
Low Today
$2.50
Open Price
$2.61
Volume
700.35K
52 Week High
$15.00
52 Week Low
$2.50

ATNX Earnings

-$0.53
-$0.35
-$0.18
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
-$0.37 per share
Actual
Available Nov 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure